In an analysis of 1109 breast cancer samples and 113 normal breast samples [34], SOCS2 and SOCS3 showed lower expression levels in cancer tissues than in normal tissues, and patients with high expression of SOCS2, SOCS3 and SOCS4 exhibited better outcome. This evidence concerns the gene SOCS2 and breast carcinoma.